Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Gastroenterology
- Vol. 43 (3), 368-374
- https://doi.org/10.1080/00365520701679181
Abstract
Objective. Propofol sedation for mainly diagnostic endoscopic procedures has proved safe in recent trials, with no need for endotracheal intubation. However, there is evidence that cardiorespiratory side effects occur more frequently and that assisted ventilation may be necessary if propofol sedation is performed for interventional endoscopic procedures. Material and methods. Over a 6-year period, all adverse events (defined as premature termination of the procedure due to sedation-related events or either the need for assisted ventilation or admission to ICU) occurring during 9547 endoscopic interventions (UGI, n=5.374, ERCP, n=3.937, EUS, n=236) under propofol sedation were assessed. Results. A total of 135 adverse events (1.4%) were documented. Assisted ventilation was necessary in 40 patients (0.4%); 9 patients required endotracheal intubation (0.09%); 28 needed further monitoring on the ICU (0.3%); and 4 patients died, 3 potentially due to sedation-related side effects (mortality, 0.03%). Independent risk factors for sedation-related side effects were emergency endoscopic examinations and a total propofol dose >100 mg. Conclusions. Interventional endoscopy under propofol sedation is not risk-free. Increased attention must be focused on close monitoring of vital parameters, particularly when undertaking long-lasting interventions and emergency procedures.Keywords
This publication has 28 references indexed in Scilit:
- Efficacy and safety of nurse-administered propofol sedation during emergency upper endoscopy for gastrointestinal bleeding: a prospective studyEndoscopy, 2006
- Propofol/Midazolam Vs Propofol/Ketamine in Patients Undergoing Gastrointestinal EndoscopiesGastrointestinal Endoscopy, 2006
- Endoscopic debridement of paraesophageal, mediastinal abscesses: a prospective case seriesGastrointestinal Endoscopy, 2005
- Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patientsSurgical Endoscopy, 2004
- Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: A prospective observational study of more than 2000 casesGastrointestinal Endoscopy, 2003
- Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: A randomized, controlled trialGastrointestinal Endoscopy, 2002
- Synergistic Sedation with Low-Dose Midazolam and Propofol for ColonoscopiesEndoscopy, 2000
- Propofol Versus Midazolam for Conscious Sedation Guided by Processed EEG During Endoscopic Retrograde Cholangiopancreatography: A Prospective, Randomized, Double-Blind StudyEndoscopy, 2000
- Improved Sedation in Diagnostic and Therapeutic ERCP: Propofol is an Alternative to MidazolamEndoscopy, 2000
- Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopyGastrointestinal Endoscopy, 1991